Alpha Teknova, Inc.
TKNONasdaqHealthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $40.5M | $37.7M | $36.7M | $41.4M | $36.9M | $31.3M |
| Operating income | −$17.0M | −$26.1M | −$35.6M | −$49.7M | −$12.0M | $4.7M |
| Net income | −$17.3M | −$26.7M | −$36.8M | −$47.5M | −$9.8M | $3.6M |
| Total assets | $103.6M | $118.8M | $128.6M | $152.3M | $166.5M | $62.9M |
| Total liabilities | $34.8M | $36.4M | $38.6M | $52.4M | $23.3M | $10.5M |
| Equity | $68.8M | $82.4M | $90.0M | $99.9M | $143.2M | $16.8M |
| EPS (diluted) | $-0.32 | $-0.57 | $-1.16 | $-1.69 | $-0.61 | $0.16 |
| Shares out. | 53.4M | 40.8M | 28.2M | 28.0M | 28.0M | 3.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −41.9%
- Net margin
- −42.6%
- Return on equity
- −25.1%
- Return on assets
- −16.7%
- Return on capital (ROCE)
- −17.7%
- Liabilities / assets
- 33.6%
- Debt / equity
- 0.51×
- Book value / share
- $1.29
- Revenue growth (YoY)
- 7.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -1.59distress
- Accruals / assets
- −8.3%clean
- Beneish M-Score
- -3.02normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Lowell MatthewOfficer — Chief Financial Officer | Mar 6, 2026 | Buy | 40,000 | $2.19 |
| Gunstream StephenOfficer — President and CEO | Mar 6, 2026 | Buy | 26,000 | $2.15 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.3M | 12.4 | -3.2% |
| Apr 30, 2026 | 1.3M | 15.9 | -1.4% |
| Apr 15, 2026 | 1.3M | 9.3 | -1.4% |
| Mar 31, 2026 | 1.3M | 11.2 | +1.6% |
| Mar 13, 2026 | 1.3M | 8.5 | -5.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer change · Shareholder voteJun 1, 2026
- Results of operations · Item 5.05May 6, 2026
- Results of operationsFeb 26, 2026
- Results of operationsNov 6, 2025
- Results of operationsAug 7, 2025
- Shareholder voteJun 23, 2025
- Results of operationsMay 8, 2025
- Entered a material agreement · Results of operationsMar 4, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KJun 1, 2026
- 10-QMay 7, 2026
- 8-KMay 6, 2026
- ARSApr 21, 2026
- DEFA14AApr 21, 2026
- DEF 14AApr 21, 2026
- 4PRIMARY DOCUMENTMar 9, 2026
- 4PRIMARY DOCUMENTMar 9, 2026
- 4PRIMARY DOCUMENTMar 9, 2026
- 10-KMar 2, 2026
- 8-KFeb 26, 2026
- 10-QNov 7, 2025
- 8-KNov 6, 2025
- 10-QAug 8, 2025
- 8-KAug 7, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.